Romagnoli et al. suggested that CD3+ T cells cultured with DCs derived exosome-treated breast cancer cells, which exhibited a significantly higher proportion of IFN-γ-secreting cells, indicating that incorporation of DC-derived exosomes by the breast cancer cells could activate T-cells for a potentially more effective cancer immunotherapy [51]. This evidence concerns the gene IFNG and cancer.